Format

Send to

Choose Destination
Methods Mol Biol. 2017;1506:283-294.

Report on Liver Cell Transplantation Using Human Fetal Liver Cells.

Author information

1
Hepatology Unit, Department of Medicine, Mediterranean Institute for Transplantation and Advanced Specialized Therapies, IRCCS-ISMETT, Palermo, Italy. gpietrosi@ismett.edu.
2
Fondazione Ri.MED, Regenerative Medicine and Biomedical Technologies Unit, Department of Laboratory Medicine and Advanced Biotechnologies, IRCCS-ISMETT, Palermo, Italy.

Abstract

In an era of organ shortage, human fetuses donated after medically indicated abortion could be considered a potential liver donor for hepatic cell isolation. We investigated transplantation of fetal liver cells as a strategy to support liver functionality in end-stage liver disease. Here, we report our protocol of human fetal liver cells (hFLC) isolation in fetuses from 17 to 22 gestational weeks, and our clinical procedure of hFLC transplantation through the splenic artery.

KEYWORDS:

Chronic liver disease; Collagenase perfusion; Fetal liver; Fetal stem cell transplantation; Liver cell transplantation; Liver progenitors; Liver stem cell isolation

PMID:
27830561
DOI:
10.1007/978-1-4939-6506-9_20
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center